Forecast Period | 2026-2030 |
Market Size (2024) | USD 35.38 Million |
CAGR (2025-2030) | 4.81% |
Fastest Growing Segment | Sample Preservation & Storage |
Largest Market | West India |
Market Size (2030) | USD 46.37 Million |
Market Overview
The Cord Blood Banking Market in India was valued at USD 35.38 million in 2024 and is projected to reach USD 46.37 million by 2030, expanding at a CAGR of 4.81% during the forecast period. This steady growth reflects rising awareness of stem cell therapies and expanding opportunities within India’s evolving healthcare ecosystem.
Cord blood the blood remaining in the umbilical cord and placenta after childbirth is a rich source of hematopoietic stem cells used in the treatment of various medical conditions, including certain cancers, genetic disorders, and blood-related diseases. Growing clinical evidence supporting stem cell–based therapies is strengthening the long-term relevance of cord blood banking in India.
Private cord blood banks currently account for a significant share of the market, offering families the option to store cord blood for personal or family use. Demand for private banking has increased due to the perceived value of having an immediately available stem cell source for future medical emergencies. Improved preservation technologies, targeted marketing campaigns, and rising disposable incomes among urban populations have further supported adoption.
Public cord blood banks, in contrast, collect donated cord blood units for use by unrelated patients in need. This model is gaining momentum due to its potential to support life-saving treatments on a broader scale. Public banks benefit from government support and partnerships with hospitals and research institutions, which help expand awareness and accessibility.
Key growth drivers in the Cord Blood Banking Market in India include increasing public and clinical awareness of stem cell therapy, proactive education by healthcare professionals, and growing media coverage of regenerative medicine. However, the market also faces challenges most notably the high cost of private cord blood banking, which can limit adoption in India’s price-sensitive healthcare landscape.
Despite these constraints, ongoing education initiatives, gradual cost optimization, and the expansion of public banking infrastructure are expected to support sustained growth in India's cord blood banking market over the coming years.
Key Market Drivers
Growing Prevalence of Autoimmune
Diseases
The rising prevalence of autoimmune diseases is emerging as a growth driver for the cord blood banking market in India because families are increasingly considering long-horizon, regenerative care options for immune mediated disorders, even as most clinical use cases remain tightly regulated and evidence-led. For instance, rheumatoid arthritis alone shows a sizeable and female-skewed burden in India, with an estimated 2,766,749 people living with rheumatoid arthritis in 2021 including 2,062,348 females versus 704,401 males, and female prevalence and other burden metrics consistently higher than males, which helps explain why women are disproportionately impacted and why awareness within families is rising.
This gender skew is also consistent with broader autoimmune epidemiology, where women account for as many as 4 out of 5 autoimmune patients in widely cited estimates, amplifying household risk perception and interest in future oriented health safeguards around childbirth. At the same time, India’s regulatory and scientific guidance frames expectations around clinical utility, as ICMR and DBT national stem cell guidelines clarify that stem cell use in patients beyond approved hematopoietic stem cell reconstitution is investigational and should only occur within approved and monitored clinical trials, while also noting that establishment and licensing of umbilical cord blood stem cell banks falls under the purview of DCGI, reinforcing that cord blood preservation demand is being shaped by both medical promise and formal oversight.
Increased Number of Hospitals
and Clinics Offering Cord Blood Banking
Cord blood banking is increasingly being integrated into routine childbirth services across hospitals and maternity clinics in India, improving awareness, accessibility and convenience for expectant parents. Availability at the point of care allows families to make informed decisions during prenatal consultations and delivery, supporting higher adoption rates.
Expansion of healthcare infrastructure, particularly in Tier 2 and Tier 3 cities, is extending cord blood banking services beyond major metropolitan areas. Supported by public and private investment, India’s healthcare sector is projected to reach USD 50 billion by 2033. According to the Ministry of Health and Family Welfare, the country has 3,840 licensed blood banks, with additional support provided through initiatives such as the National Health Mission. This institutional integration is strengthening trust and sustaining growth in India’s cord blood banking market.
Download Free Sample Report
Key Market Challenges
High Cost Associated with Cord
Blood Banking
The high cost of cord blood banking remains a major challenge limiting adoption in India. While cord blood banking offers significant potential for future stem cell–based therapies, the overall expense creates a financial barrier for many families and constrains broader market penetration.
Cord blood banking involves multiple cost-intensive stages, including collection, processing and long-term storage. Collection requires trained medical personnel and sterile equipment to safely extract umbilical cord blood immediately after birth. Processing is conducted in specialized laboratories using advanced technologies to isolate and preserve viable stem cells, adding to operational costs through skilled labor and infrastructure investment.
Following processing, cord blood units must be cryogenically stored at extremely low temperatures to maintain long-term viability. This requires specialized storage facilities, continuous temperature monitoring and backup power systems, significantly increasing ongoing costs. These cumulative expenses are typically passed on to consumers through upfront and recurring fees.
According to a report by Kauvery Hospital, most private cord blood banks charge an initial fee covering collection, processing and cryopreservation, often exceeding USD 1,100, along with annual storage fees of more than USD 700. For many families, particularly in a price-sensitive and economically diverse market such as India, these costs are prohibitive.
As a result, high pricing limits access to cord blood banking services and restricts adoption primarily to higher-income groups, acting as a key restraint on the growth of India’s cord blood banking market.
Key Market Trends
Growth of Stem Cell Research
The rapid advancement of stem cell research is a key factor reshaping the cord blood banking market in India. Expanding scientific understanding of stem cell applications in regenerative medicine is increasing the clinical relevance of cord blood banking and strengthening its role in future healthcare planning.
Stem cells derived from umbilical cord blood have demonstrated therapeutic potential in treating conditions such as leukemia, lymphoma and certain genetic and immune-related disorders. As research continues to validate and expand these applications, interest in cord blood banking is rising among healthcare providers, researchers and expectant parents seeking long-term medical security.
Government support has played a central role in accelerating stem cell research. In February 2022, India advanced national stem cell initiatives through coordinated efforts across multiple agencies, including the Indian Council of Medical Research, the Department of Biotechnology and the Department of Science and Technology. These programs supported both basic and clinical research, leading to the development of advanced infrastructure across more than 40 leading health research and academic institutions.
The expansion of research capabilities is directly influencing demand for cord blood banking. As clinical trials progress and stem cell therapies demonstrate improved outcomes, stored cord blood is increasingly viewed as a valuable biological resource. This growing recognition is encouraging more parents to consider cord blood banking as a proactive healthcare measure.
In parallel, increased collaboration between cord blood banks, research institutions and biotechnology firms is strengthening the market. These partnerships support access to advanced technologies, improved storage standards and alignment with the latest scientific developments. Together, sustained investment in stem cell research and expanding clinical validation are expected to drive long-term growth and innovation in India’s cord blood banking market.
Segmental Insights
Service Insights
Based on service type, sample preservation and storage emerged as the fastest-growing segment in the India cord blood banking market in 2024. Effective preservation and long-term storage are critical due to the sensitive nature of stem cells and their potential use in future medical treatments. Once collected, cord blood samples must be processed and stored under strictly controlled conditions to maintain stem cell viability and therapeutic effectiveness.
The preservation process includes collection, processing, cryopreservation and long-term storage, each requiring precise handling and quality control. Growing awareness of the long-term clinical value of high-quality stem cell samples is driving demand for reliable preservation and storage services. Parents are increasingly viewing cord blood banking as a long-term healthcare investment rather than a short-term decision.
Technological advancements in cryopreservation are further supporting segment growth. Innovations such as controlled-rate freezing and vitrification have improved the efficiency and reliability of stem cell preservation, enabling cells to remain viable over extended storage periods. In parallel, the development of advanced storage facilities equipped with temperature-controlled freezers, continuous monitoring systems and backup infrastructure is enhancing trust in cord blood banking services. The ability to offer secure, long-term storage has become a key competitive differentiator for providers in India.
Component Insights
Based on component, cord blood has emerged as the dominant segment in the India cord blood banking market during the forecast period. This dominance is primarily driven by rising awareness among expectant parents about the therapeutic potential of cord blood–derived stem cells. Educational initiatives and public awareness efforts have highlighted their use in treating conditions such as certain cancers, genetic disorders and autoimmune diseases, encouraging greater adoption.
Advancements in medical research and stem cell technology have further reinforced the importance of cord blood banking. Ongoing clinical research has expanded the range of potential applications in regenerative medicine, strengthening confidence in cord blood as a valuable biological resource. As scientific validation continues to grow, demand for cord blood banking services is expected to remain strong.
Supportive regulatory frameworks and government oversight have also contributed to market growth by ensuring quality, safety and standardization across cord blood banking services. These measures help build consumer confidence and encourage wider adoption. In addition, the increasing availability of cord blood banking through hospitals and maternity clinics often bundled into childbirth packages—has improved accessibility and simplified decision-making for expectant parents, reinforcing the segment’s market dominance.
Download Free Sample Report
Regional Insights
Based
on Region, West India have emerged as the dominating region in the India Cord
Blood Banking Market in 2024. One of the primary drivers of West India's
prominence in the cord blood banking sector is its well-developed healthcare
infrastructure. The region, particularly Maharashtra and Gujarat, is home to a
significant number of advanced medical facilities and institutions. Cities such
as Mumbai and Pune in Maharashtra, and Ahmedabad and Surat in Gujarat, boast
state-of-the-art hospitals and specialized healthcare centers that are equipped
with the necessary technology and expertise for cord blood collection and
processing. The presence of these high-quality medical facilities provides a
strong foundation for the growth and development of cord blood banking
services.
Furthermore,
West India benefits from a high concentration of affluent and educated families
who are more likely to invest in advanced medical services, including cord
blood banking. The region's economic prosperity has led to an increased focus
on healthcare and preventive measures, with many families seeking to safeguard
their health through the use of innovative technologies. This economic
advantage translates into higher demand for cord blood banking services,
driving the growth of the market in West India.
The
region has also seen a significant rise in public awareness and education
regarding the benefits of cord blood banking. Healthcare providers and cord
blood banks in West India have undertaken extensive educational campaigns to
inform expectant parents about the potential life-saving advantages of storing
cord blood stem cells. Increased awareness and understanding of the value of
cord blood for treating various diseases have led to higher adoption rates
among families in West India.
Additionally,
West India’s strategic geographic location enhances its position in the cord
blood banking market. The region’s well-connected transport and logistics
networks facilitate the efficient collection, processing, and storage of cord
blood. Major cities in West India have access to advanced transportation
infrastructure, including airports and ports, which ensures that cord blood can
be quickly and safely transported to processing facilities. This logistical
efficiency is crucial for maintaining the viability of the cord blood stem
cells and ensuring timely delivery.
Recent Development
- In December 2025, Cryoviva listed Social Banking benefits including “20 Lakh Financial Assistance” to help offset transplant expenses for the child, biological parent, or biological sibling during the child’s first 21 years.
- In December 2025, Cryoviva described its “Social Banking” approach as a stem cell preservation option that allows social banking members to access a larger pool of stem cells to increase the chance of a match and reduce dependence on public banks or bone marrow registries.
- In July 2025, LifeCell positioned its Community Stem Cell Banking program as a distinct offering versus traditional private-only cord blood storage.
- In
August 2024, LifeCell, a leading name in stem cell banking, diagnostics,
genetic testing, and pre-conception care in India, is set to revolutionize
mother-baby skincare with the launch of AreoVeda. This innovative product line
is tailored for pregnant women, new mothers, and newborns, meeting the highest
standards of purity, potency, and safety. By harnessing the regenerative
properties of natural ingredients, LifeCell provides a scientifically-backed
approach to clean skincare, setting new benchmarks in the industry.
Key Market Players
- Cryoviva
Biotech Pvt. Ltd.
- LifeCell
International Pvt Ltd.
- Cordlife
Sciences India Pvt Ltd.
- Regrow
Biosciences Pvt. Ltd.
- ReeLabs
Pvt. Ltd.
- StemCyte
India Therapeutics Pvt. Ltd.
- Reliance
Life Sciences Pvt. Ltd./India.
|
By
Service
|
By
Component
|
By
Application
|
By
Sector
|
By
Region
|
- Sample
Preservation & Storage
- Sample
Analysis
- Sample
Processing
- Sample
Collection & Transportation
|
|
- Cancer Disease
- Diabetes
- Blood Disease
- Immune Disorders
- Metabolic Disorders
- Others
|
- Public Cord Blood Banks
- Private cord Blood Banks
|
- North
India
- East
India
- West
India
- South
India
|
Report Scope
In this report, the India Cord Blood Banking Market
has been segmented into the following categories, in addition to the industry
trends which have also been detailed below:
- India Cord Blood Banking Market, By Service:
o Sample Preservation & Storage
o Sample Analysis
o Sample Processing
o Sample Collection & Transportation
- India Cord Blood Banking Market, By Component:
o Cord Blood
o Cord Tissue
- India Cord Blood Banking Market, By Application:
o Cancer Disease
o Diabetes
o Blood Disease
o Immune Disorders
o Metabolic Disorders
o Others
- India Cord Blood Banking Market, By Sector:
o Public Cord Blood Banks
o Private cord Blood Banks
- India Cord Blood Banking Market, By Region:
o North India
o East India
o West India
o South India
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the India Cord
Blood Banking Market.
Available Customizations:
India Cord Blood Banking Market report with the
given market data, Tech Sci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
India Cord Blood
Banking Market is an upcoming report to be released soon. If you wish an early
delivery of this report or want to confirm the date of release, please contact
us at
[email protected]